Filing Details
- Accession Number:
- 0001209191-19-058714
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-12-03 16:32:39
- Reporting Period:
- 2019-11-29
- Accepted Time:
- 2019-12-03 16:32:39
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 879169 | Incyte Corp | INCY | Services-Commercial Physical & Biological Research (8731) | 943136539 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1624033 | Yao Wenqing | 1801 Augustine Cut-Off Wilmington DE 19803 | Evp, Head Of Discovery Chem | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-11-29 | 3,165 | $18.32 | 98,473 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-11-29 | 3,165 | $95.00 | 95,308 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2019-12-02 | 16,835 | $18.32 | 112,143 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-12-02 | 16,835 | $95.00 | 95,308 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2019-11-29 | 3,165 | $0.00 | 3,165 | $18.32 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2019-12-02 | 16,835 | $0.00 | 16,835 | $18.32 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 34,377 | 2020-02-08 | No | 4 | M | Direct | |
| 17,542 | 2020-02-08 | No | 4 | M | Direct |
Footnotes
- This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person.
- This includes an aggregate of 63,951 shares of common stock issuable pursuant to previously reported restricted stock units and earnedperformance stock units that have not vested.
- Beginning February 9, 2013, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years
Billionaire Hedge Funds
